A retrospective cohort study to evaluate improvement of beta cell function due to early treatment with Liraglutide in patients with Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 25 Oct 2016
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Oct 2016 New trial record